Table 2. Validation of Gompertz-Predicted Median Life Expectancy by Risk Points.
HRS Development Cohort | HRS Validation Cohort | ELSA Validation Cohort | ||
PointScore | Gompertz-Predicted Median Life Expectancy,in years (95% CI), [50% PI] | Observed MedianSurvival, in years | Observed MedianSurvival, in years | Observed MedianSurvival, in years |
0 | 35.4 (31.0–39.8) [28.5–42.5] | >10* | >10* | >8* |
1 | 33.1 (29.9–36.2) [23.7–37.5] | >10* | >10* | >8* |
2 | 30.1 (28.1–32.0) [22.0–35.6] | >10* | >10* | >8* |
3 | 23.7 (22.4–24.9) [16.5–29.6] | >10* | >10* | >8* |
4 | 21.1 (20.0–22.1) [14.1–26.7] | >10* | >10* | >8* |
5 | 17.7 (16.8–18.5) [11.2–23.0] | >10* | >10* | >8* |
6 | 14.3 (13.7–15.0) [8.4–19.2] | >10* | >10* | >8* |
7 | 12.6 (12.0–13.2) [7.0–17.2] | >10* | >10* | >8* |
8 | 10.3 (9.7–10.9) [5.6–14.9] | 9.9 | 10.0 | >8* |
9 | 8.8 (8.2–9.3) [4.8–13.3] | 8.3 | 8.9 | >8* |
10 | 7.3 (6.7–7.8) [3.8–11.4] | 6.8 | 7.2 | >8* |
11 | 5.9 (5.3–6.4) [2.9–9.3] | 5.4 | 5.0 | 7.4 |
12 | 5.3 (4.7–5.8) [2.6–8.8] | 4.6 | 5.1 | 6.7 |
13 | 4.8 (4.1–5.4) [2.2–7.6] | 4.0 | 3.8 | 6.5 |
≥14 | 3.4 (3.0–3.8) [1.7–6.2] | 3.1 | 2.9 | 4.2 |
Harrell’s c-statistic | 0.790 | 0.779 | 0.801 |
*Follow-up for HRS is limited to 10 years while the follow-up for ELSA is limited to 8 years.
CI is confidence interval.
PI is prediction interval.